two
cyclodepsipeptid
known
cyclodepsipeptid
valinomycin
isol
cultur
marin
actinomycet
streptomyc
sp
structur
establish
base
nmr
hresim
msm
spectroscop
interpret
well
chemic
degrad
streptodepsipeptid
inhibit
prolifer
differ
glioma
cell
line
ic
valu
rang
mm
mm
streptodepsipeptid
found
block
cell
cycl
g
g
phase
induc
apoptosi
glioma
cell
investig
demonstr
streptodepsipeptid
downregul
express
gl
fasn
import
tumor
metabol
enzym
data
studi
suggest
target
multipl
tumor
metabol
regul
might
one
antiglioma
mechan
streptodepsipeptid
possibl
mechan
class
streptodepsipeptid
report
herein
glioma
common
high
death
malign
brain
tumor
patil
et
al
ru
et
al
locat
mani
import
brain
function
area
make
surgic
resect
extrem
difficult
therefor
chemotherapi
play
import
role
treatment
prevent
glioma
howev
far
drug
approv
treat
glioma
includ
temozolomid
tmz
carmustin
lomustin
tmz
independ
use
treatment
glioma
furthermor
current
antiglioma
drug
cytotoxicitybas
alkyl
agent
limit
efficaci
seriou
sideeffect
chamberlain
mittal
et
al
therefor
urgent
need
discov
lead
compound
develop
novel
antiglioma
drug
marinederiv
natur
product
import
sourc
discoveri
new
anticanc
drug
lead
newman
cragg
petit
biard
schumach
et
al
enhanc
glycolysi
elev
glutaminolysi
exacerb
lipogenesi
requir
rapid
unlimit
prolifer
tumor
cell
demonstr
promin
hallmark
glioma
metabol
galluzzi
et
al
guo
et
al
vander
heiden
ru
et
al
sever
import
regul
enzym
glycolyt
pathway
hexokinas
vander
heiden
wolf
et
al
kessler
et
al
vander
heiden
pyruv
kinas
kefa
et
al
vander
heiden
shown
upregul
glioma
cell
specif
regul
preferenti
use
cancer
cell
vander
heiden
glutamin
metabol
day
wellen
ru
et
al
lipid
metabol
ru
et
al
santo
schulz
also
found
larg
alter
cancer
cell
glutaminas
gl
key
enzym
glutaminolysi
day
wellen
lu
et
al
ru
et
al
fatti
acid
synthas
fasn
key
lipogen
enzym
menendez
lupu
ru
et
al
upregul
glioma
accumul
studi
demonstr
mention
metabol
enzym
promis
target
discoveri
novel
anticanc
drug
part
ongo
project
discoveri
novel
antiglioma
antibacteri
compound
marin
resourc
chen
et
al
liang
et
al
xin
et
al
yu
et
al
yu
et
al
crude
extract
prepar
cultur
marin
bacterium
strain
found
significantli
inhibit
prolifer
human
glioma
cell
chemic
investig
activ
extract
led
isol
two
new
cyclodepsipeptid
name
streptodepsipeptid
togeth
known
valinomycin
fig
studi
describ
isol
cultur
strain
isol
structur
elucid
new
compound
bioactiv
glioma
cell
effect
tumor
metabol
regul
strain
isol
marin
mud
sampl
assign
streptomyc
sp
base
analysi
rdna
gene
sequenc
match
ident
bp
stretch
sequenc
seven
streptomyc
strain
supplementari
data
figur
tabl
cultur
marin
actinomycet
grown
gaus
liquid
medium
l
extract
prepar
cultur
show
signific
activ
prolifer
human
glioma
cell
inhibit
glioma
cell
cell
separ
activ
extract
od
column
chromatographi
follow
hplc
purif
afford
three
compound
compound
prove
known
cyclodepsipeptid
valinomycin
base
nmr
hresim
data
melt
point
optic
rotat
valu
analysi
acid
hydrolys
chiral
hplc
gc
analys
comparison
literatur
data
pettit
et
al
tabeta
saito
valinomycin
previous
isol
sever
streptomyc
speci
heisey
et
al
lim
et
al
park
et
al
pettit
et
al
well
known
enhanc
k
permeabl
sever
membran
system
includ
mitochondria
erythrocyt
lipid
bilay
bhattacharyya
et
al
hayn
et
al
cyclodepsipeptid
also
report
activ
tumor
bacteria
fungi
lim
et
al
park
et
al
pettit
et
al
sever
acut
respiratorysyndrom
coronaviru
wu
et
al
valinomycin
compos
four
unit
dvalin
dval
lvalin
lval
dahydroxyisovaler
acid
dhiv
llactat
llac
trimer
structur
cyclo
dvalllaclvaldhiv
c
h
nmr
spectroscop
data
assign
see
tabl
supplementari
data
note
four
unit
display
characterist
nmr
signal
allow
differenti
four
unit
unit
llac
easili
recogn
nmr
signal
c
h
q
j
hz
j
hz
dhiv
characterist
signal
c
h
j
hz
dval
lval
could
distinguish
chemic
shift
coupl
constant
valu
j
chnh
unit
dval
indic
characterist
nmr
signal
c
h
dd
j
hz
j
hz
compar
counterpart
lval
c
h
dd
j
hz
j
hz
characterist
nmr
signal
mention
help
structur
elucid
new
compound
streptodepsipeptid
fifth
zone
assign
methylen
bch
remain
carbon
appear
c
sixth
zone
assign
methyl
gch
bch
h
nmr
spectrum
also
show
six
nh
signal
h
hz
hz
hz
hz
hz
hz
data
suggest
compound
compos
unit
includ
six
amid
group
amino
acid
six
ester
group
acid
hydrolysi
produc
dval
lval
dhiv
llac
acid
dhba
determin
chiral
hplc
gc
analys
use
standard
compound
refer
detail
cosi
hsqc
hmbc
spectroscop
analys
confirm
presenc
unit
includ
three
llactat
three
lvalin
three
dvalin
two
dahydroxyisovaler
acid
one
acid
dhba
shown
fig
anh
ach
proton
valin
cosi
correl
ach
proton
unit
display
cosi
correl
bch
bch
dhba
bch
llac
proton
correl
gch
proton
hmbc
correl
see
tabl
fig
support
structur
unit
accord
forego
nmr
correl
nmr
data
comparison
sequenc
unit
compound
establish
base
follow
hmbc
noesi
correl
tabl
order
confirm
locat
lval
dval
compound
partial
hydrolyz
use
lioh
produc
three
dipeptid
llaclval
dhivdval
dhbadval
structur
fig
deduc
hresim
h
nmr
data
acid
hydrolysi
furnish
free
amino
acid
lval
dval
confirm
chiral
hplc
analysi
use
standard
amino
acid
refer
sequenc
unit
compound
also
support
result
msm
analysi
msm
spectrum
c
c
c
c
lval
c
ch
c
c
dhiv
ch
c
c
c
c
lval
c
ch
c
c
dhba
ch
dd
c
c
c
lval
c
ch
c
c
llac
c
ch
q
c
c
dval
c
ch
c
c
llac
c
ch
q
c
c
dval
c
ch
c
c
llac
c
ch
q
c
c
dval
c
ch
c
c
aechen
ch
c
c
lval
ch
dd
c
c
c
c
ch
c
c
lval
ch
dd
c
c
c
c
ch
c
c
lval
ch
dd
c
c
c
c
dhiv
ch
c
c
dval
ch
dd
c
c
c
c
ch
c
c
dval
ch
dd
c
c
c
c
dhba
ch
c
c
dval
ch
dd
c
c
c
c
nh
bech
lval
c
c
llac
c
llac
ch
c
c
lval
c
c
llac
c
ch
c
c
lval
c
c
llac
c
ch
c
c
dval
c
c
dhbac
bech
dval
c
c
dhiv
c
dhba
ch
c
c
c
dval
c
c
dhiv
c
bech
ac
data
label
column
may
interchang
fragment
ringopen
amid
posit
loss
carbon
monoxid
co
fig
compound
isol
strain
might
overal
biosynthet
pathway
suggest
similar
sequenc
unit
base
evid
structur
determin
cyclo
methyl
c
acid
hydrolys
found
dval
lval
dhiv
llac
determin
chiral
hplc
gc
detail
nmr
spectroscop
analysi
combin
hresim
data
indic
structur
similar
except
anoth
llac
moieti
instead
dhba
moieti
c
h
nmr
data
tabl
three
isol
cyclodepsipeptid
assay
activ
prolifer
four
differ
glioma
cell
line
srb
method
result
fig
tabl
show
new
streptodepsipeptid
potent
activ
ic
valu
mm
mm
known
valinomycin
show
much
stronger
antiprolif
activ
ic
valu
rang
nm
probabl
symmetr
trimer
structur
pettit
et
al
control
doxorubicin
dox
activ
ic
mm
two
new
compound
also
test
activ
inhibit
growth
normal
human
astrocyt
ha
shown
tabl
ratio
ic
ha
glioma
cell
within
rang
streptodepsipeptid
also
assay
abil
arrest
cell
cycl
induc
apoptosi
glioma
cell
flow
cytometr
analysi
use
measur
dna
content
determin
alter
cell
cycl
occur
follow
treatment
streptodepsipeptid
cell
incub
mm
streptodepsipeptid
dox
mm
posit
control
without
compound
treatment
neg
control
con
h
stain
pi
subject
flow
cytometr
analysi
percentag
phase
cell
cycl
describ
fig
tabl
cell
popul
g
g
phase
significantli
increas
treatment
h
compar
control
con
alter
indic
streptodepsipeptid
block
cell
cycl
g
g
phase
posit
control
dox
mm
also
increas
dna
content
g
g
phase
similar
result
also
obtain
streptodepsipeptid
cell
fig
tabl
flow
cytometr
analysi
annexin
vfitcpi
doubl
stain
appli
quantifi
apoptosi
induc
streptodepsipeptid
h
treatment
streptodepsipeptid
mm
caus
increas
total
apoptot
cell
earli
late
apoptot
cell
compar
control
con
fig
streptodepsipeptid
investig
effect
sever
import
tumor
metabol
regul
includ
glycolysi
glycolysi
glycolysi
gl
glutaminolysi
fasn
lipogenesi
firstli
express
level
gl
fasn
four
differ
glioma
cell
line
test
western
blot
found
five
tumor
metabol
regul
highli
express
cell
fig
thu
effect
streptodepsipeptid
express
level
regul
cell
evalu
cell
treat
streptodepsipeptid
mm
mm
h
protein
prepar
streptodepsipeptid
cell
subject
western
blot
analysi
result
fig
indic
gl
fasn
highli
downregul
streptodepsipeptid
cell
compar
neg
control
con
cell
tabl
activ
streptodepsipeptid
obviou
effect
atpb
express
level
increas
level
cytoc
data
suggest
streptodepsipeptid
might
select
regul
tumor
metabol
regul
gl
fasn
increas
express
level
cytoc
also
impli
streptodepsipeptid
might
chang
tumor
metabol
pathway
process
oxid
phosphoryl
valinomycin
known
induc
uptak
potassium
membran
erythrocyt
bhattacharyya
et
al
therefor
abil
streptodepsipeptid
enhanc
k
permeabl
human
erythrocyt
also
evalu
human
erythrocyt
treat
test
compound
posit
control
valinomycin
min
result
tabl
show
streptodepsipeptid
concentr
mm
mm
mm
induc
increas
intracellular
k
erythrocyt
respect
compar
neg
control
con
human
erythrocyt
without
compound
treatment
posit
control
valinomycin
concentr
also
enhanc
k
uptak
respect
data
indic
valinomycin
streptodepsipeptid
properti
significantli
induc
uptak
k
membran
erythrocyt
small
molecular
compound
report
antitumor
activ
target
tumor
metabol
regul
hexokinas
hk
inhibitor
lonidamin
inhibitor
shikonin
tln
fan
inhibitor
orlista
cerulenin
egcg
galluzzi
et
al
jone
schulz
menendez
lupu
note
activ
antitumor
agent
target
one
tumor
metabol
regul
interestingli
streptodepsipeptid
obviou
effect
sever
import
tumor
metabol
regul
differ
metabol
pathway
propos
modul
multipl
target
could
benefici
prevent
treatment
complex
human
diseas
cancer
bishaye
block
morphi
rankov
whether
streptodepsipeptid
potenti
develop
novel
anticanc
drug
need
evalu
actinomycet
streptomyc
sp
produc
antiprolif
cyclodepsipeptid
isol
sampl
marin
mud
chemic
investig
crude
extract
prepar
cultur
isol
strain
result
isol
identif
two
new
cyclodepsipeptid
name
streptodepsipeptid
found
new
cyclodepsipeptid
significantli
suppress
prolifer
four
differ
glioma
cell
line
investig
demonstr
streptodepsipeptid
induc
apoptosi
glioma
cell
arrest
cell
cycl
g
g
phase
downregul
express
level
gl
fasn
import
tumor
metabol
regul
glycolysi
glutaminolysi
lipogenesi
result
indic
regul
multipl
glioma
metabol
enzym
might
one
antitumor
mechan
streptodepsipeptid
best
knowledg
first
report
possibl
mechan
class
streptodepsipeptid
howev
streptodepsipeptid
regul
metabol
regul
antiglioma
activ
new
bioactiv
cyclodepsipeptid
anim
model
need
investig
melt
point
measur
microscop
apparatu
uncorrect
optic
rotat
measur
jasco
digit
polarimet
ir
spectra
record
avatar
ftir
spectromet
thermo
nicolet
atom
absorpt
spectrometri
perkinelm
co
ltd
use
determin
concentr
nmr
spectra
acquir
bruker
spectromet
use
standard
puls
program
acquisit
paramet
chemic
shift
express
ppm
refer
nmr
solvent
cdcl
hresim
data
acquir
agil
tof
lcm
spectromet
msm
data
obtain
ab
tripl
tof
plu
system
ab
sciex
framingham
usa
optim
ms
condit
scan
rang
mz
posit
ion
mode
sourc
voltag
kv
sourc
temperatur
c
air
ga
pressur
psi
curtain
ga
n
psi
maximum
error
ppm
collis
energi
v
collis
energi
spread
v
separ
pure
compound
conduct
agil
hplc
system
dad
detector
chirex
penicillamin
column
nm
phenomenex
shanghai
china
use
chiral
hplc
analysi
gc
analysi
conduct
agil
ga
chromatograph
system
use
capillari
column
mm
mm
agil
technolog
n
mlmin
use
carrier
ga
fid
detector
detector
inject
port
temperatur
set
c
c
respect
column
temperatur
c
min
rais
cmin
c
kept
c
min
octadecylfunction
silica
gel
od
cosmosil
prep
nacalai
tesqu
inc
kyoto
japan
use
column
chromatographi
cc
hplc
analyt
grade
solvent
purchas
sinopharm
chemic
reagent
co
ltd
shanghai
china
doxorubicin
dox
dvalin
dval
lvalin
lval
llactat
llac
dahydroxyisovaler
acid
dhiv
acid
dhba
purchas
sigma
human
glioma
cell
rat
glioma
cell
purchas
cell
bank
chines
academi
scienc
normal
human
astrocyt
ha
cat
obtain
sciencel
gausesagar
purchas
guangdong
huankai
microbi
scienc
technolog
co
ltd
guangzhou
china
strain
isol
mud
sampl
marin
tidal
flat
collect
coast
east
china
sea
close
zhoushan
citi
china
august
marin
mud
sampl
g
dri
c
day
steril
cultur
dish
dri
sampl
dilut
gml
steril
natur
sea
water
shaken
rotari
shaker
rpm
c
min
suspens
sampl
ml
coat
across
plate
gausesagar
medium
incub
c
day
singl
coloni
strain
grew
well
transfer
onto
gausesagar
media
work
stock
prepar
gausesagar
slant
store
c
use
taxonom
ident
isol
strain
determin
rdna
sequenc
analysi
conduct
majorbio
shanghai
china
dna
sequenc
use
blast
nucleotid
sequenc
comparison
compar
genbank
databas
rdna
sequenc
strain
deposit
genbank
access
number
voucher
strain
streptomyc
sp
preserv
laboratori
institut
marin
biolog
ocean
colleg
zhejiang
univers
china
homogen
coloni
isol
transfer
ml
erlenmey
flask
contain
ml
gaus
liquid
medium
incub
day
c
rotari
shaker
rpm
produc
seed
broth
seed
broth
ml
inocul
ml
erlenmey
flask
contain
ml
gaus
liquid
medium
flask
incub
c
rotari
shaker
rpm
day
total
l
ferment
broth
made
studi
ferment
broth
isol
strain
l
filter
harvest
pellet
ferment
solut
pellet
tabl
valinomycin
streptodepsipeptid
induc
uptak
potassium
membran
erythrocyt
con
mgml
mm
mm
mm
streptodepsipeptid
mg
hydrolyz
use
lioh
ml
meoh
h
vv
gentl
shake
room
temperatur
h
reaction
mixtur
neutral
hcl
ph
dri
reduc
pressur
give
residu
hydrolyt
product
mg
r
min
mg
r
min
mg
r
mi
next
purifi
residu
hplc
use
zorbax
sbc
column
mm
mm
condit
flow
rate
mlmin
detect
wavelength
nm
gradient
mobil
phase
meoh
water
employ
mobil
phase
phase
b
respect
binari
gradient
program
min
phase
min
phase
phase
llaclval
acid
hydrolysi
valinomycin
streptodepsipeptid
llaclval
dhivdval
dhbadval
valinomycin
streptodepsipeptid
mg
individu
dissolv
hcl
ml
heat
c
evacu
glass
ampoul
h
cool
hydrolys
dri
n
vacuum
give
correspond
residu
half
residu
dissolv
h
ml
produc
sampl
chiral
hplc
analysi
remain
residu
dissolv
meoh
ml
give
sampl
b
gc
analysi
way
llaclval
mg
dhivdval
mg
dhbadval
mg
individu
hydrolyz
give
sampl
c
e
respect
chiral
hplc
analysi
streptodepsipeptid
sampl
c
e
prepar
authent
dval
lval
analyz
use
chirex
penicillamin
column
nm
phenomenex
detect
nm
temperatur
c
aqueou
cuso
mm
use
mobil
phase
free
amino
acid
acid
hydrolys
valinomycin
streptodepsipeptid
found
lvalin
r
min
dvalin
r
min
comparison
retent
time
authent
amino
acid
acid
product
llaclval
dhivdval
dhivdval
found
lval
dval
sampl
b
prepar
compound
analyz
gc
gc
analys
show
valinomycin
streptodepsipeptid
produc
llac
dhiv
streptodepsipeptid
produc
llac
dhba
dhiv
compar
authent
llac
r
min
dhba
r
min
dhiv
r
min
sulforhodamin
b
srb
assay
previous
describ
sulforhodamin
b
srb
assay
chen
et
al
yu
et
al
yu
et
al
appli
evalu
activ
isol
streptodepsipeptid
inhibit
prolifer
glioma
cell
doxorubicin
dox
use
posit
control
con
annexin
vfitcpi
doubl
stain
assay
quantif
apoptot
cell
induc
streptodepsipeptid
made
annexin
vfitcpi
doubl
stain
use
annexin
v
apoptosi
detect
kit
chen
et
al
yu
et
al
yu
et
al
glioma
cell
treat
test
compound
h
flow
cytometri
use
determin
fluoresc
use
emiss
wavelength
nm
nm
excit
wavelength
nm
cell
cycl
assay
cell
cycl
perturb
induc
streptodepsipeptid
analyz
propidium
iodid
pi
dna
stain
use
flow
cytometri
detail
protocol
describ
xin
et
al
western
blot
analysi
western
blot
use
determin
express
level
metabol
regul
detail
procedur
includ
protein
sampl
prepar
determin
protein
concentr
western
blot
analysi
carri
yu
et
al
determin
intracellular
k
concentr
bhattacharyya
et
al
li
yang
lu
et
al
briefli
fresh
healthi
human
blood
centrifug
g
min
c
precipit
erythrocyt
wash
gn
glucos
normal
salin
inject
buffer
gl
glucos
gl
nacl
centrifug
g
min
three
repeat
oper
wash
erythrocyt
suspend
gn
buffer
make
erythrocyt
suspens
prepar
erythrocyt
suspens
ml
treat
differ
concentr
test
compound
kcl
isoton
solut
ml
min
c
termin
treatment
use
ice
bath
min
treat
suspens
centrifug
g
min
treat
erythrocyt
wash
cold
gn
ml
five
time
remov
extracellular
k
haemolyz
ultrapur
h
c
overnight
haemolyz
solut
centrifug
g
min
c
give
cytoplasm
cell
membran
cell
membran
wash
ultrapur
h
two
time
ml
give
wash
solut
centrifug
g
min
afford
supernat
combin
ml
supernat
cytoplasm
digest
use
mixtur
ml
moll
hno
moll
hclo
v
v
c
min
clear
transpar
liquid
ml
appear
digest
solut
transfer
volumetr
flask
ml
dilut
hno
full
volum
ml
digest
solut
dilut
hno
time
make
final
digest
solut
measur
intracellular
k
concentr
atom
absorpt
spectrometri
seri
accur
k
solut
prepar
kcl
investig
calibr
curv
r
k
concentr
sampl
calcul
calibr
curv
